Detalhe da pesquisa
1.
Predictors of Loss to Follow-Up Among Pediatric and Adult Hematopoietic Cell Transplantation Survivors: A Report from the Center for International Blood and Marrow Transplant Research.
Biol Blood Marrow Transplant
; 26(3): 553-561, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31726205
2.
Association of Antiepileptic Medications with Outcomes after Allogeneic Hematopoietic Cell Transplantation with Busulfan/Cyclophosphamide Conditioning.
Biol Blood Marrow Transplant
; 25(7): 1424-1431, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30871976
3.
Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML.
Blood Adv
; 6(3): 828-847, 2022 01 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34551064
4.
Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR.
Leukemia
; 35(7): 2076-2085, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33785862
5.
Myeloablative Conditioning for Allogeneic Transplantation Results in Superior Disease-Free Survival for Acute Myelogenous Leukemia and Myelodysplastic Syndromes with Low/Intermediate but not High Disease Risk Index: A Center for International Blood and Marrow Transplant Research Study.
Transplant Cell Ther
; 27(1): 68.e1-68.e9, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33010430
6.
Allogeneic Transplantation to Treat Therapy-Related Myelodysplastic Syndrome and Acute Myelogenous Leukemia in Adults.
Transplant Cell Ther
; 27(11): 923.e1-923.e12, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34428556
7.
Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study.
Lancet Haematol
; 6(11): e585-e596, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31495699
8.
Correction: Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR.
Leukemia
; 35(7): 2140, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34088982